- £190.62bn
- £211.49bn
- $45.81bn
- 79
- 12
- 97
- 70
REG - AstraZeneca PLC - AstraZeneca to deliver $80bn revenue by 2030
AnnouncementREG - AstraZeneca PLC - AstraZeneca to manufacture ADCs in Singapore
AnnouncementREG - AstraZeneca PLC - SUPERNOVA Trial Met COVID-19 prevention endpoint
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca completes Cellectis equity investment
AnnouncementREG - AstraZeneca PLC - Calquence combination improved PFS in 1L MCL
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - 1st Quarter Results
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/04/2024
AnnouncementREG - AstraZeneca PLC - Result of AGM
AnnouncementREG - AstraZeneca PLC - AstraZeneca increases 2024 dividend by 7%
AnnouncementREG - AstraZeneca PLC - Enhertu approved in US for HER2+ solid tumours
AnnouncementREG - AstraZeneca PLC - Imfinzi improved OS & PFS in limited-stage SCLC
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Voydeya approved in US
AnnouncementREG - AstraZeneca PLC - FDA accepts Dato-DXd BLA for breast cancer
AnnouncementREG - AstraZeneca PLC - Ultomiris approved in the US for NMOSD
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire Fusion
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire Amolyt
Announcement